Stem Cell Research & Therapy, 2024 · DOI: https://doi.org/10.1186/s13287-024-04077-5 · Published: November 22, 2024
Spinal cord injury (SCI) involves a complex series of reactions where mitochondrial damage and dysfunction play a central role by disrupting energy metabolism. These disruptions worsen the initial injury and hinder nerve regeneration. Strategies like enhancing mitochondrial transport or transplanting mitochondria aim to restore energy supply, modulate inflammation, and prevent cell death, offering potential approaches for SCI repair. Mitochondrial transplantation (MT) has shown promise in preclinical studies by reducing neuronal death, promoting axon regeneration, and regulating signaling pathways involved in cell survival and tissue repair.
Mitochondrial transplantation (MT) offers a promising therapeutic approach for spinal cord injury (SCI) by restoring energy supply, modulating inflammation, and promoting tissue regeneration.
MT could be used to reduce neuronal death, enhance axonal regeneration, and decrease glial scar formation in SCI patients, potentially improving motor function recovery.
Further studies are needed to determine the optimal sources, dosages, administration methods, and timing of MT for SCI treatment to develop effective clinical protocols.